Hyalohyphomycosis

Clinical Mycology

Volumn , Issue , 2009, Pages 309-327

  Nucci, Marcio ^a   Anaissie, Elias J ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858600828     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5680-5.00013-X     Document Type: Chapter

References (231)

1. Guarro J., Gams W., Pujol I., Gene J. Acremonium species: new emerging fungal opportunists - in vitro antifungal susceptibilities and review. Clin Infect Dis 1997, 25:1222.
2. Lamaris G.A., Chamilos G., Lewis R.E., et al. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis 2006, 43:1580.
3. Nucci M., Anaissie E. Emerging fungi. Infect Dis Clin North Am 2006, 20:563.
4. Okhravi N., Lightman S. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2007, 13:554.
5. Pastor F.J., Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect 2006, 12:948.
6. Vanittanakom N., Cooper C.R., Fisher M.C., Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev 2006, 19:95.
7. Nucci M., Anaissie E.J., Queiroz-Telles F., et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003, 98:315.
8. Nucci M., Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007, 20:695.
9. Austen B., McCarthy H., Wilkins B., et al. Fatal disseminated Fusarium infection in acute lymphoblastic leukaemia in complete remission. J Clin Pathol 2001, 54:488.
10. Boutati E.I., Anaissie E.J. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997, 90:999.
11. Guarro J., Nucci M., Akiti T., et al. Fungemia due to Fusarium sacchari in an immunosuppressed patient. J Clin Microbiol 2000, 38:419.
12. Guarro J., Nucci M., Akiti T., Gene J. Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol 2000, 38:3460.
13. Krcmery V., Jesenska Z., Spanik S., et al. Fungaemia due to Fusarium spp. in cancer patients. J Hosp Infect 1997, 36:223.
14. Nelson P.E., Dignani M.C., Anaissie E.J. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994, 7:479.
15. Kratka J., Kovacikova E. The effect of temperature and age of strains of Fusarium oxysporum on its enzymatic activity. Zentralbl Bakteriol Naturwiss 1979, 134:154.
16. Mayayo E., Pujol I., Guarro J. Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol 1999, 48:363.
17. Silveira F.P., Queiroz-Telles F., Nucci M. Invasive mold infections. Diagnosis of Fungal Infections 2007, 171. Informa Healthcare, New York. J.A. Maertens, K.A. Marr (Eds.).
18. St-Germain G., Summerbell R.C. Fusarium. Identifying Filamentous Fungi 1996, 122. Blackwell Science, Belmont, CA. G. St-Germain, R.C. Summerbell (Eds.).
19. Nucci M., Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002, 35:909.
20. Doczi I., Gyetvai T., Kredics L., Nagy E. Involvement of Fusarium spp. in fungal keratitis. Clin Microbiol Infect 2004, 10:773.
21. Update: Fusarium keratitis - United States, 2005-2006. MMWR 2006, 55:563.
22. Rippon J.W., Larson R.A., Rosenthal D.M., Clayman J. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: three cases and review of the literature. Mycopathologia 1988, 101:105.
23. Kerr C.M., Perfect J.R., Craven P.C., et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med 1983, 99:334.
24. Flynn J.T., Meislich D., Kaiser B.A., et al. Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature. Perit Dial Int 1996, 16:52.
25. Kurien M., Anandi V., Raman R., Brahmadathan K.N. Maxillary sinus fusariosis in immunocompetent hosts. J Laryngol Otol 1992, 106:733.
26. Madhavan M., Ratnakar C., Veliath A.J., et al. Primary disseminated fusarial infection. Postgrad Med J 1992, 68:143.
27. Sander A., Beyer U., Amberg R. Systemic Fusarium oxysporum infection in an immunocompetent patient with an adult respiratory distress syndrome (ARDS) and extracorporeal membrane oxygenation (ECMO). Mycoses 1998, 41:109.
28. Murray C.K., Beckius M.L., McAllister K. Fusarium proliferatum superficial suppurative thrombophlebitis. Mil Med 2003, 168:426.
29. Sturm A.W., Grave W., Kwee W.S. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet 1989, 1:968.
30. Pflugfelder S.C., Flynn H.W., Zwickey T.A., et al. Exogenous fungal endophthalmitis. Ophthalmology 1988, 95:19.
31. Gabriele P., Hutchins R.K. Fusarium endophthalmitis in an intravenous drug abuser. Am J Ophthalmol 1996, 122:119.
32. Jakle C., Leek J.C., Olson D.A., Robbins D.L. Septic arthritis due to Fusarium solani. J Rheumatol 1983, 10:151.
33. Bourguignon R.L., Walsh A.F., Flynn J.C., et al. Fusarium species osteomyelitis. Case report. J Bone Joint Surg Am 1976, 58:722.
34. Chang D.C., Grant G.B., O'Donnell K., et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 2006, 296:953.
35. Saw S.M., Ooi P.L., Tan D.T., et al. Risk factors for contact lens-related Fusarium keratitis: a case-control study in Singapore. Arch Ophthalmol 2007, 125:611.
36. Nucci M., Marr K.A., Queiroz-Telles F., et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004, 38:1237.
37. Sampathkumar P., Paya C.V. Fusarium infection after solid-organ transplantation. Clin Infect Dis 2001, 32:1237.
38. Anaissie E., Kantarjian H., Ro J., et al. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 1988, 67:77.
39. Merz W.G., Karp J.E., Hoagland M., et al. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis 1988, 158:1046.
40. Brint J.M., Flynn P.M., Pearson T.A., Pui C.H. Disseminated fusariosis involving bone in an adolescent with leukemia. Pediatr Infect Dis J 1992, 11:965.
41. Rombaux P., Eloy P., Bertrand B., et al. Lethal disseminated Fusarium infection with sinus involvement in the immunocompromised host: case report and review of the literature. Rhinology 1996, 34:237.
42. Raad I., Tarrand J., Hanna H., et al. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect Control Hosp Epidemiol 2002, 23:532.
43. Anaissie E.J., Kuchar R.T., Rex J.H., et al. Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis 2001, 33:1871.
44. O'Donnell K., Sutton D.A., Rinaldi M.G., et al. Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin. J Clin Microbiol 2004, 42:5109.
45. Calado N.B., Sousa F., Gomes N.O., et al. Fusarium nail and skin infection: a report of eight cases from Natal, Brazil. Mycopathologia 2006, 161:27.
46. Hay R.J. Fusarium infections of the skin. Curr Opin Infect Dis 2007, 20:115.
47. Guilhermetti E., Takahachi G., Shinobu C.S., Svidzinski T.I. Fusarium spp. as agents of onychomycosis in immunocompetent hosts. Int J Dermatol 2007, 46:822.
48. Guarro J., Gene J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995, 14:741.
49. Liu K., Howell D.N., Perfect J.R., Schell W.A. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 1998, 109:45.
50. Hayden R.T., Isotalo P.A., Parrett T., et al. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol 2003, 12:21.
51. Healy M., Reece K., Walton D., et al. Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol 2005, 43:5278.
52. Odabasi Z., Mattiuzzi G., Estey E., et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004, 39:199.
53. Ostrosky-Zeichner L., Alexander B.D., Kett D.H., et al. Multicenter clinical evaluation of the (1->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005, 41:654.
54. Anaissie E.J., Stratton S.L., Dignani M.C., et al. Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin Infect Dis 2002, 35:E86.
55. Dignani M.C., Anaissie E.J., Hester J.P., et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 1997, 11:1621.
56. Hennequin C., Benkerrou M., Gaillard J.L., et al. Role of granulocyte colony-stimulating factor in the management of infection with Fusarium oxysporum in a neutropenic child. Clin Infect Dis 1994, 18:490.
57. Anaissie E.J., Rinaldi M.G. Fusarium and the immunocompromised host: liaisons dangeureuses. N Y State J Med 1990, 90:586.
58. Bushelman S.J., Callen J.P., Roth D.N., Cohen L.M. Disseminated Fusarium solani infection. J Am Acad Dermatol 1995, 32:346.
59. Duong T.A. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996, 23:125.
60. Antinori S., Gianelli E., Bonaccorso C., et al. Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. J Travel Med 2006, 13:181.
61. Carey J., Hofflich H., Amre R., et al. Penicillium marneffei infection in an immunocompromised traveler: a case report and literature review. J Travel Med 2005, 12:291.
62. Supparatpinyo K., Khamwan C., Baosoung V., et al. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994, 344:110.
63. Fisher M.C., Aanensen D., de Hoog S., Vanittanakom N. Multilocus microsatellite typing system for Penicillium marneffei reveals spatially structured populations. J Clin Microbiol 2004, 42:5065.
64. Jones P.D., See J. Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity. Clin Infect Dis 1992, 15:744.
65. Barcus A.L., Burdette S.D., Herchline T.E. Intestinal invasion and disseminated disease associated with Penicillium chrysogenum. Ann Clin Microbiol Antimicrob 2005, 4:21.
66. Mok T., Koehler A.P., Yu M.Y., et al. Fatal Penicillium citrinum pneumonia with pericarditis in a patient with acute leukemia. J Clin Microbiol 1997, 35:2654.
67. St-Germain G., Summerbell R.C. Penicillium. Identifying Filamentous Fungi 1996, 166. Blackwell Science, Belmont, CA. G. St-Germain, R.C. Summerbell (Eds.).
68. Richardson M.D., Warnock D.W. Penicillium marneffei. Fungal Infections: Diagnosis and Management 1997, Blackwell Science, Malden, MD. M.D. Richardson, D.W. Warnock (Eds.).
69. Chariyalertsak S., Sirisanthana T., Supparatpinyo K., Nelson K.E. Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir?. J Infect Dis 1996, 173:1490.
70. Deesomchok A., Tanprawate S. A 12-case series of Penicillium marneffei pneumonia. J Med Assoc Thai 2006, 89:441.
71. Deng Z., Ribas J.L., Gibson D.W., Connor D.H. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 1988, 10:640.
72. Sirisanthana T. Infection due to Penicillium marneffei. Ann Acad Med Singapore 1997, 26:701.
73. Sirisanthana V., Sirisanthana T. Penicillium marneffei infection in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1993, 12:1021.
74. Ma E.S., Ho P.L. Disseminated Penicillium marneffei infection. Br J Haematol 2005, 130:2.
75. Wortman P.D. Infection with Penicillium marneffei. Int J Dermatol 1996, 35:393.
76. Supparatpinyo K., Chiewchanvit S., Hirunsri P., et al. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1992, 14:871.
77. Cheng N.C., Wong W.W., Fung C.P., Liu C.Y. Unusual pulmonary manifestations of disseminated Penicillium marneffei infection in three AIDS patients. Med Mycol 1998, 36:429.
78. Chaiyaroj S.C., Chawengkirttikul R., Sirisinha S., et al. Antigen detection assay for identification of Penicillium marneffei infection. J Clin Microbiol 2003, 41:432.
79. Chaiwarith R., Charoenyos N., Sirisanthana T., Supparatpinyo K. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART. AIDS 2007, 21:365.
80. Bouza E., Munoz P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin Microbiol Infect 2004, 10(suppl 1):76.
81. O'Bryan T.A. Pseudallescheriasis in the 21st century. Expert Rev Anti Infect Ther 2005, 3:765.
82. Panackal A.A., Marr K.A. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med 2004, 25:171.
83. St-Germain G., Summerbell R.C. Scedosporium. Identifying Filamentous Fungi 1996, 180. Blackwell Science, Belmont, CA. G. St-Germain, R.C. Summerbell (Eds.).
84. Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003, 16:607.
85. Husain S., Munoz P., Forrest G., et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005, 40:89.
86. Nagano Y., Millar B.C., Goldsmith C.E., et al. Emergence of Scedosporium apiospermum in patients with cystic fibrosis. Arch Dis Child 2007, 92:607.
87. Baumgartner B.J., Rakita R.M., Backous D.D. Scedosporium apiospermum otomycosis. Am J Otolaryngol 2007, 28:254.
88. Bhat S.V., Paterson D.L., Rinaldi M.G., Veldkamp P.J. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis 2007, 39:87.
89. Chen F.K., Chen S.D., Tay-Kearney M.L. Intravitreal voriconazole for the treatment of endogenous endophthalmitis caused by Scedosporium apiospermum. Clin Experiment Ophthalmol 2007, 35:382.
90. Katragkou A., Dotis J., Kotsiou M., et al. Scedosporium apiospermum infection after near-drowning. Mycoses 2007, 50:412.
91. Dalton P.A., Munckhof W.J., Walters D.W. Scedosporium prolificans: an uncommon cause of septic arthritis. Aust NZ J Surg 2006, 76:661.
92. Koga T., Kitajima T., Tanaka R., et al. Chronic pulmonary scedosporiosis simulating aspergillosis. Respirology 2005, 10:682.
93. Verghese S., Padmaja P., Chellamma M.T., et al. Prosthetic valve endocarditis caused by Scedosporium apiospermum. Indian J Med Microbiol 2005, 23:264.
94. Rogasi P.G., Zanazzi M., Nocentini J., et al. Disseminated Scedosporium apiospermum infection in renal transplant recipient: long-term successful treatment with voriconazole: a case report. Transplant Proc 2007, 39:2033.
95. de Marco L.E., Sadaba P., Lastra Garcia-Baron P., et al. Cerebral scedosporiosis: an emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation. Eur Radiol 2006, 16:496.
96. Musk M., Chambers D., Chin W., et al. Successful treatment of disseminated Scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management. J Heart Lung Transplant 2006, 25:1268.
97. Pagano L., Caira M., Falcucci P., Fianchi L. Fungal CNS infections in patients with hematologic malignancy. Expert Rev Anti Infect Ther 2005, 3:775.
98. Uenotsuchi T., Moroi Y., Urabe K., et al. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature. Acta Derm Venereol 2005, 85:156.
99. Castiglioni B., Sutton D.A., Rinaldi M.G., et al. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 2002, 81:333.
100. Revankar S.G., Patterson J.E., Sutton D.A., et al. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002, 34:467.
101. Maertens J., Lagrou K., Deweerdt H., et al. Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review. Ann Hematol 2000, 79:340.
102. Berenguer J., Rodriguez-Tudela J.L., Richard C., et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group. Medicine (Baltimore) 1997, 76:256.
103. Nenoff P., Gutz U., Tintelnot K., et al. Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses 1996, 39:461.
104. Madrigal V., Alonso J., Bureo E., et al. Fatal meningoencephalitis caused by Scedosporium inflatum (Scedosporium prolificans) in a child with lymphoblastic leukemia. Eur J Clin Microbiol Infect Dis 1995, 14:601.
105. Bryan C.S., DiSalvo A.F., Kaufman L., et al. Petriellidium boydii infection of the sphenoid sinus. Am J Clin Pathol 1980, 74:846.
106. Dworzack D.L., Clark R.B., Borkowski W.J., et al. Pseudallescheria boydii brain abscess: association with near-drowning and efficacy of high-dose, prolonged miconazole therapy in patients with multiple abscesses. Medicine (Baltimore) 1989, 68:218.
107. Garzoni C., Emonet S., Legout L., et al. Atypical infections in tsunami survivors. Emerg Infect Dis 2005, 11:1591.
108. Ruchel R., Wilichowski E. Cerebral Pseudallescheria mycosis after near-drowning. Mycoses 1995, 38:473.
109. Gari M., Fruit J., Rousseaux P., et al. Scedosporium (Monosporium) apiospermum: multiple brain abscesses. Sabouraudia 1985, 23:371.
110. Hachimi-Idrissi S., Willemsen M., Desprechins B., et al. Pseudallescheria boydii and brain abscesses. Pediatr Infect Dis J 1990, 9:737.
111. Montero A., Cohen J.E., Fernandez M.A., et al. Cerebral pseudallescheriasis due to Pseudallescheria boydii as the first manifestation of AIDS. Clin Infect Dis 1998, 26:1476.
112. Berenguer J., az-Mediavilla J., Urra D., Munoz P. Central nervous system infection caused by Pseudallescheria boydii: case report and review. Rev Infect Dis 1989, 11:890.
113. Rosen P., Adelson H.T., Burleigh E. Bronchiectasis complicated by the presence of Monosporium apiospermum and Aspergillus fumigatus. Am J Clin Pathol 1969, 52:182.
114. Arnett J.C., Hatch H.B. Pulmonary allescheriasis. Report of a case and review of the literature. Arch Intern Med 1975, 135:1250.
115. Lake F.R., Tribe A.E., McAleer R., et al. Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus. Thorax 1990, 45:489.
116. Miller M.A., Greenberger P.A., Amerian R., et al. Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii. Am Rev Respir Dis 1993, 148:810.
117. Nomdedeu J., Brunet S., Martino R., et al. Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report. Clin Infect Dis 1993, 16:731.
118. Walsh M., White L., Atkinson K., Enno A. Fungal Pseudoallescheria boydii lung infiltrates unresponsive to amphotericin B in leukaemic patients. Aust NZ J Med 1992, 22:265.
119. Winer-Muram H.T., Vargas S., Slobod K. Cavitary lung lesions in an immunosuppressed child. Chest 1994, 106:937.
120. Rabodonirina M., Paulus S., Thevenet F., et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis 1994, 19:138.
121. Wood G.M., McCormack J.G., Muir D.B., et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992, 14:1027.
122. St-Germain G., Summerbell R.C. Paecilomyces. Identifying Filamentous Fungi 1996, 162. Blackwell Science, Belmont, CA. G. St-Germain, R.C. Summerbell (Eds.).
123. Erbagci Z., Tuncel A.A., Erkilic S., Zer Y. Successful treatment of antifungal- and cryotherapy-resistant subcutaneous hyalohyphomycosis in an immunocompetent case with topical 5% imiquimod cream. Mycopathologia 2005, 159:521.
124. Gutierrez F., Masia M., Ramos J., et al. Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections. Eur J Clin Microbiol Infect Dis 2005, 24:607.
125. Hall V.C., Goyal S., Davis M.D., Walsh J.S. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature. Int J Dermatol 2004, 43:648.
126. Tarkkanen A., Raivio V., Anttila V.J., et al. Fungal endophthalmitis caused by Paecilomyces variotii following cataract surgery: a presumed operating room air-conditioning system contamination. Acta Ophthalmol Scand 2004, 82:232.
127. Garbino J., Ondrusova A., Baglivo E., et al. Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 2002, 34:701.
128. Gutierrez-Rodero F., Moragon M., Ortiz de la Tabla V., et al. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review. Eur J Clin Microbiol Infect Dis 1999, 18:814.
129. Lott M.E., Sheehan D.J., Davis L.S. Paecilomyces lilacinus infection with a sporotrichoid pattern in a renal transplant patient. J Drugs Dermatol 2007, 6:436.
130. van Schooneveld T, Freifeld A, Lesiak B, et al. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 2007, epub ahead of print [not on PubMed as of 7 March 2008.
131. Chamilos G., Kontoyiannis D.P. Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis. J Infect 2005, 51:e225.
132. Salle V., Lecuyer E., Chouaki T., et al. Paecilomyces variotii fungemia in a patient with multiple myeloma: case report and literature review. J Infect 2005, 51:e93.
133. Wang S.M., Shieh C.C., Liu C.C. Successful treatment of Paecilomyces variotii splenic abscesses: a rare complication in a previously unrecognized chronic granulomatous disease child. Diagn Microbiol Infect Dis 2005, 53:149.
134. Shing M.M., Ip M., Li C.K., et al. Paecilomyces variotii fungemia in a bone marrow transplant patient. Bone Marrow Transplant 1996, 17:281.
135. Strahilevitz J., Rahav G., Schroers H.J., et al. An outbreak of Phialemonium infective endocarditis linked to intracavernous penile injections for the treatment of impotence. Clin Infect Dis 2005, 40:781.
136. Orth B., Frei R., Itin P.H., et al. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 1996, 125:799.
137. St-Germain G., Summerbell R.C. Acremonium. Identifying Filamentous Fungi 1996, 54. Blackwell Science, Belmont, CA. G. St-Germain, R.C. Summerbell (Eds.).
138. Gupta A.K., Gregurek-Novak T. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. Dermatology 2001, 202:235.
139. Onsberg P., Stahl D. Scopulariopsis onychomycosis treated with natamycin. Dermatologica 1980, 160:57.
140. Del Prete A., Sepe G., Ferrante M., et al. Fungal keratitis due to Scopulariopsis brevicaulis in an eye previously suffering from herpetic keratitis. Ophthalmologica 1994, 208:333.
141. Hennequin C., el-Bez M., Trotoux J., Simonet M. [Scopulariopsis brevicaulis otomycosis after tympanoplasty]. Ann Otolaryngol Chir Cervicofac 1994, 111:353.
142. Jabor M.A., Greer D.L., Amedee R.G. Scopulariopsis: an invasive nasal infection. Am J Rhinol 1998, 12:367.
143. Gentry L.O., Nasser M.M., Kielhofner M. Scopulariopsis endocarditis associated with Duran ring valvuloplasty. Tex Heart Inst J 1995, 22:81.
144. Migrino R.Q., Hall G.S., Longworth D.L. Deep tissue infections caused by Scopulariopsis brevicaulis: report of a case of prosthetic valve endocarditis and review. Clin Infect Dis 1995, 21:672.
145. Mohammedi I., Piens M.A., Udigier-Valette C., et al. Fatal Microascus trigonosporus (anamorph Scopulariopsis) pneumonia in a bone marrow transplant recipient. Eur J Clin Microbiol Infect Dis 2004, 23:215.
146. Ng K.P., Soo-Hoo T.S., Na S.L., et al. Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia. Med J Malaysia 2003, 58:608.
147. Nwabuisi C., Salami A.K., Abdullahi N.A., Agbede O.O. Scopulariopsis associated meningitis in adult Nigerian AIDS patient - a case report. West Afr J Med 2003, 22:364.
148. Martel J., Faisant M., Lebeau B., et al. [Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient]. Ann Dermatol Venereol 2001, 128:130.
149. Sellier P., Monsuez J.J., Lacroix C., et al. Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient. Clin Infect Dis 2000, 30:820.
150. Phillips P., Wood W.S., Phillips G., Rinaldi M.G. Invasive hyalohyphomycosis caused by Scopulariopsis brevicaulis in a patient undergoing allogeneic bone marrow transplant. Diagn Microbiol Infect Dis 1989, 12:429.
151. Neglia J.P., Hurd D.D., Ferrieri P., Snover D.C. Invasive Scopulariopsis in the immunocompromised host. Am J Med 1987, 83:1163.
152. Wheat L.J., Bartlett M., Ciccarelli M., Smith J.W. Opportunistic Scopulariopsis pneumonia in an immunocompromised host. South Med J 1984, 77:1608.
153. Gueho E., Villard J., Guinet R. A new human case of Anixiopsis stercoraria mycosis: discussion of its taxonomy and pathogenicity. Mykosen 1985, 28:430.
154. Xi L., Fukushima K., Lu C., et al. First case of Arthrographis kalrae ethmoid sinusitis and ophthalmitis in the People's Republic of China. J Clin Microbiol 2004, 42:4828.
155. Chin-Hong P.V., Sutton D.A., Roemer M., et al. Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDS. J Clin Microbiol 2001, 39:804.
156. Degavre B., Joujoux J.M., Dandurand M., Guillot B. First report of mycetoma caused by Arthrographis kalrae: successful treatment with itraconazole. J Am Acad Dermatol 1997, 37:318.
157. Perlman E.M., Binns L. Intense photophobia caused by Arthrographis kalrae in a contact lens-wearing patient. Am J Ophthalmol 1997, 123:547.
158. Kisla T.A., Cu-Unjieng A., Sigler L., Sugar J. Medical management of Beauveria bassiana keratitis. Cornea 2000, 19:405.
159. McDonnell P.J., Werblin T.P., Sigler L., Green W.R. Mycotic keratitis due to Beauveria alba. Cornea 1984, 3:213.
160. Sachs S.W., Baum J., Mies C. Beauvaria bassiana keratitis. Br J Ophthalmol 1985, 69:548.
161. Lomwardias S., Madge G.E. Chaetoconidium and atypical acid-fast bacilli in skin ulcers. Arch Dermatol 1972, 106:875.
162. Roilides E., Sigler L., Bibashi E., et al. Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non- Aspergillus fungal infections in patients with this disease. J Clin Microbiol 1999, 37:18.
163. Warwick A., Ferrieri P., Burke B., Blazar B.R. Presumptive invasive Chrysosporium infection in a bone marrow transplant recipient. Bone Marrow Transplant 1991, 8:319.
164. Gan G.G., Kamarulzaman A., Goh K.Y., et al. Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient. Med J Malaysia 2002, 57:118.
165. Levy F.E., Larson J.T., George E., Maisel R.H. Invasive Chrysosporium infection of the nose and paranasal sinuses in an immunocompromised host. Otolaryngol Head Neck Surg 1991, 104:384.
166. Wagoner M.D., Badr I.A., Hidayat A.A. Chrysosporium parvum keratomycosis. Cornea 1999, 18:616.
167. Bambirra E.A., Nogueira A.M. Human pulmonary granulomas caused by Chrysosporium parvum var. crescens (Emmonsia crescens). Am J Trop Med Hyg 1983, 32:1184.
168. Toshnirval R., Goodman S., Ally S.A., et al. Endocarditis due to Chrysosporium species: a disease of medical progress?. J Infect Dis 1986, 153:638.
169. Stillwell W.T., Rubin B.D., Axelrod J.L. Chrysosporium, a new causative agent in osteomyelitis. A case report. Clin Orthop Relat Res 1984, 184:190.
170. Maran A.G., Kwong K., Milne L.J., Lamb D. Frontal sinusitis caused by Myriodontium keratinophilum. BMJ 1985, 290:207. (Clin Res Ed).
171. Garg J., Tilak R., Gulati A.K., et al. Scytalidium infection associated with dyskeratosis congenita. Br J Dermatol 2007, 156:604.
172. Morris-Jones R., Youngchim S., Hextall J.M., et al. Scytalidium dimidiatum causing recalcitrant subcutaneous lesions produces melanin. J Clin Microbiol 2004, 42:3789.
173. Aamir S., Aman S., Haroon T. Mycetoma caused by Scytalidium dimidiatum. Br J Dermatol 2003, 148:174.
174. Hay R.J. Scytalidium infections. Curr Opin Infect Dis 2002, 15:99.
175. Gugnani H.C., Oyeka C.A. Foot infections due to Hendersonula toruloidea and Scytalidium hyalinum in coal miners. J Med Vet Mycol 1989, 27:167.
176. Zaatari G.S., Reed R., Morewessel R. Subcutaneous hyphomycosis caused by Scytalidium hyalinum. Am J Clin Pathol 1984, 82:252.
177. Romano C., Valenti L., Difonzo E.M. Two cases of tinea pedis caused by Scytalidium hyalinum. J Eur Acad Dermatol Venereol 1999, 12:38.
178. Farjo Q.A., Farjo R.S., Farjo A.A. Scytalidium keratitis: case report in a human eye. Cornea 2006, 25:1231.
179. Dunn J.J., Wolfe M.J., Trachtenberg J., et al. Invasive fungal sinusitis caused by Scytalidium dimidiatum in a lung transplant recipient. J Clin Microbiol 2003, 41:5817.
180. De Miguel D., Gomez P., Gonzalez R., et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect Dis 2005, 53:33.
181. Myoken Y., Sugata T., Fujita Y., et al. Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report. Int J Oral Maxillofac Surg 2002, 31:688.
182. Guarro J., Antolin-Ayala M.I., Gene J., et al. Fatal case of Trichoderma harzianum infection in a renal transplant recipient. J Clin Microbiol 1999, 37:3751.
183. Richter S., Cormican M.G., Pfaller M.A., et al. Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: species identification and review of the literature. J Clin Microbiol 1999, 37:1154.
184. Jacobs F., Byl B., Bourgeois N., et al. Trichoderma viride infection in a liver transplant recipient. Mycoses 1992, 35:301.
185. Chouaki T., Lavarde V., Lachaud L., et al. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002, 35:1360.
186. Wilson C.M., O'Rourke E.J., McGinnis M.R., Salkin I.F. Scedosporium inflatum: clinical spectrum of a newly recognized pathogen. J Infect Dis 1990, 161:102.
187. Hayden G., Lapp C., Loda F. Arthritis caused by Monosporium apiospermum treated with intraarticular amphotericin B. Am J Dis Child 1977, 131:927.
188. Piper J.P., Golden J., Brown D., Broestler J. Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole. Pediatr Infect Dis J 1990, 9:674.
189. Bouza E., Munoz P., Vega L., et al. Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor. Clin Infect Dis 1996, 23:192.
190. Cofrancesco E., Boschetti C., Viviani M.A., et al. Efficacy of liposomal amphotericin B (AmBisome) in the eradication of Fusarium infection in a leukaemic patient. Haematologica 1992, 77:280.
191. Ellis M.E., Clink H., Younge D., Hainau B. Successful combined surgical and medical treatment of Fusarium infection after bone marrow transplantation. Scand J Infect Dis 1994, 26:225.
192. Martino P., Gastaldi R., Raccah R., Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994, 28(suppl 1):7.
193. Spielberger R.T., Falleroni M.J., Coene A.J., Larson R.A. Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient. Clin Infect Dis 1993, 16:528.
194. Sirisanthana T., Supparatpinyo K., Perriens J., Nelson K.E. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1998, 26:1107.
195. Sirisanthana T., Supparatpinyo K. Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients. Int J Infect Dis 1998, 3:48.
196. Wolff M.A., Ramphal R. Use of amphotericin B lipid complex for treatment of disseminated cutaneous Fusarium infection in a neutropenic patient. Clin Infect Dis 1995, 20:1568.
197. Bunya V.Y., Hammersmith K.M., Rapuano C.J., et al. Topical and oral voriconazole in the treatment of fungal keratitis. Am J Ophthalmol 2007, 143:151.
198. Cuenca-Estrella M., Gomez-Lopez A., Mellado E., et al. In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi. Antimicrob Agents Chemother 2005, 49:5136.
199. Cuenca-Estrella M., Gomez-Lopez A., Mellado E., et al. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
200. Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 2003, 20:121.
201. Paphitou N.I., Ostrosky-Zeichner L., Paetznick V.L., et al. In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother 2002, 46:3298.
202. Arikan S., Lozano-Chiu M., Paetznick V., et al. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 1999, 37:3946.
203. Espinel-Ingroff A., Chaturvedi V., Fothergill A., Rinaldi M.G. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol 2002, 40:3776.
204. Meletiadis J., Meis J.F., Mouton J.W., et al. Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol 2000, 38:2949.
205. Pfaller M.A., Diekema D.J. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004, 42:4419.
206. Szekely A., Johnson E.M., Warnock D.W. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol 1999, 37:1480.
207. Perfect J.R., Marr K.A., Walsh T.J., et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003, 36:1122.
208. Raad I.I., Hachem R.Y., Herbrecht R., et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006, 42:1398.
209. Makowsky M.J., Warkentin D.I., Savoie M.L. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia. Ann Pharmacother 2005, 39:1365.
210. Guzman-Cottrill J.A., Zheng X., Chadwick E.G. Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 2004, 23:1059.
211. Durand-Joly I., Alfandari S., Benchikh Z., et al. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J Clin Microbiol 2003, 41:4898.
212. Rothe A., Seibold M., Hoppe T., et al. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol 2004, 83:394.
213. Howden B.P., Slavin M.A., Schwarer A.P., Mijch A.M. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003, 22:111.
214. Lupinetti F.M., Giller R.H., Trigg M.E. Operative treatment of Fusarium fungal infection of the lung. Ann Thorac Surg 1990, 49:991.
215. Velasco E., Martins C.A., Nucci M. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis 1995, 14:697.
216. Rodriguez C.A., Lujan-Zilbermann J., Woodard P., et al. Successful treatment of disseminated fusariosis. Bone Marrow Transplant 2003, 31:411.
217. Lee S.S., Lo Y.C., Wong K.H. The first one hundred AIDS cases in Hong Kong. Chin Med J (Engl) 1996, 109:70.
218. Hood S., Denning D.W. Treatment of fungal infection in AIDS. J Antimicrob Chemother 1996, 37(suppl B):71.
219. Imwidthaya P. Update of Penicillosis marneffei in Thailand. Review article. Mycopathologia 1994, 127:135.
220. Supparatpinyo K., Schlamm H.T. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients. Am J Trop Med Hyg 2007, 77:350.
221. Phillips P., Forbes J.C., Speert D.P. Disseminated infection with Pseudallescheria boydii in a patient with chronic granulomatous disease: response to gamma-interferon plus antifungal chemotherapy. Pediatr Infect Dis J 1991, 10:536.
222. McGinnis M.R., Pasarell L., Sutton D.A., et al. In vitro activity of voriconazole against selected fungi. Med Mycol 1998, 36:239.
223. Sabatelli F., Patel R., Mann P.A., et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006, 50:2009.
224. Herbrecht R., Letscher-Bru V., Fohrer C., et al. Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B. Eur J Clin Microbiol Infect Dis 2002, 21:814.
225. Mattei D., Mordini N., Lo N.C., et al. Successful treatment of Acremonium fungemia with voriconazole. Mycoses 2003, 46:511.
226. Szombathy S.P., Chez M.G., Laxer R.M. Acute septic arthritis due to Acremonium. J Rheumatol 1988, 15:714.
227. Warris A., Wesenberg F., Gaustad P., et al. Acremonium strictum fungaemia in a paediatric patient with acute leukaemia. Scand J Infect Dis 2000, 32:442.
228. Lopes J.O., Alves S.H., Rosa A.C., et al. Acremonium kiliense peritonitis complicating continuous ambulatory peritoneal dialysis: report of two cases. Mycopathologia 1995, 131:83.
229. Weissgold D.J., Orlin S.E., Sulewski M.E., et al. Delayed-onset fungal keratitis after endophthalmitis. Ophthalmology 1998, 105:258.
230. Aguilar C., Pujol I., Guarro J. In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob Agents Chemother 1999, 43:1520.
231. Hart A.P., Sutton D.A., McFeeley P.J., Kornfeld M. Cerebral phaeohyphomycosis caused by a dematiaceous Scopulariopsis species. Clin Neuropathol 2001, 20:224.